Rothschild Investment LLC Alkermes Plc. Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q4 2024
A detailed history of Rothschild Investment LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Rothschild Investment LLC holds 120 shares of ALKS stock, worth $3,691. This represents 0.0% of its overall portfolio holdings.
Number of Shares
120
Previous 105
14.29%
Holding current value
$3,691
Previous $2.94 Million
17.42%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
361Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$895 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$584 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$400 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$389 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$283 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.05B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...